Genetic causes of glioma: New leads in the labyrinth

Current Opinion in Oncology

Volumn 23, Issue 6, 2011, Pages 643-647

  Melin, Beatrice ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

EGFR; genetic variants; glioblastoma; glioma; GWAS; primary brain tumors

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; EPIDERMAL GROWTH FACTOR RECEPTOR; TELOMERASE;

CANCER GRADING; CANCER GROWTH; CANCER RISK; CHROMOSOME 11Q; CHROMOSOME 20Q; CHROMOSOME 5P; CHROMOSOME 7P; CHROMOSOME 8Q; CHROMOSOME 9P; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GLIOMA; HUMAN; IMMUNE FUNCTION TEST; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

BRAIN NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; GLIOMA; HUMANS; PENETRANCE;

EID: 80054098355     PISSN: 10408746     EISSN: 1531703X     Source Type: Journal    
DOI: 10.1097/CCO.0b013e32834a6f61     Document Type: Review

References (29)

1. Wallace MR, Marchuk DA, Andersen LB, et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 1990; 249:181-186.
2. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250:1233-1238. (Pubitemid 120031831)
3. Hegde MR, Chong B, Blazo ME, et al. A homozygous mutation in MSH6 causes Turcot syndrome. Clin Cancer Res 2005; 11:4689-4693. (Pubitemid 41557186)
4. Malmer B, Gronberg H, Bergenheim AT, et al. Familial aggregation of astrocytoma in northern Sweden: an epidemiological cohort study. Int J Cancer 1999; 81:366-370. (Pubitemid 29165194)
5. Wrensch M, Lee M, Miike R, et al. Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol 1997; 145:581-593. (Pubitemid 27154860)
6. Hemminki K, Tretli S, Sundquist J, et al. Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway. Lancet Oncol 2009; 10:481-488.
7. Shete S, Hosking FJ, Robertson LB, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 2009; 41:899-904.
8. Wrensch M, Jenkins RB, Chang JS, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 2009; 41:905-908.
9. Sanson M, Hosking FJ, Shete S, et al. Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum Mol Genet 2011.
10. Huang PH, Xu AM, White FM. Oncogenic EGFR signaling networks in glioma. Sci Signal 2009; 2:re6.
11. Ekstrand AJ, Longo N, Hamid ML, et al. Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. Oncogene 1994; 9:2313-2320. (Pubitemid 24228682)
12. Andersson U, Guo D, Malmer B, et al. Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas. Acta Neuropathol 2004; 108:135-142. (Pubitemid 39136299)
13. Bondy ML, Scheurer ME, Malmer B, et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 2008; 113 (7 Suppl):1953-1968.
14. Koff JL, Shao MX, Ueki IF, Nadel JA. Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium. Am J Physiol Lung Cell Mol Physiol 2008; 294:L1068-L1075.
15. Andersson U, Schwartzbaum J, Wiklund F, et al. A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk. Acta Oncol 2010; 49:767-775.
16. Schwartzbaum JA, Xiao Y, Liu Y, et al. Inherited variation in immune genes and pathways and glioblastoma risk. Carcinogenesis 2010; 31:1770-1777.
17. Parsons DW, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008; 321:1807-1812.
18. Bahuau M, Vidaud D, Jenkins RB, et al. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Res 1998; 58:2298-2303. (Pubitemid 28252682)
19. Robertson LB, Armstrong GN, Olver BD, et al. Survey of familial glioma and role of germline p16INK4A/p14ARF and p53 mutation. Fam Cancer 2010; 9:413-421.
20. Simon M, Hosking FJ, Marie Y, et al. Genetic risk profiles identify different molecular etiologies for glioma. Clin Cancer Res 2010; 16: 5252-5259.
21. Jenkins RB, Wrensch MR, Johnson D, et al. Distinct germ line polymorphisms underlie glioma morphologic heterogeneity. Cancer Genet 2011; 204:13-18.
22. Egan KM, Thompson RC, Nabors LB, et al. Cancer susceptibility variants and the risk of adult glioma in a US case-control study. J Neurooncol 2011. [Epub ahead of print]
23. Barber LJ, Youds JL, Ward JD, et al. RTEL1 maintains genomic stability by suppressing homologous recombination. Cell 2008; 135:261-271.
24. Liu Y, Shete S, Etzel CJ, et al. Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival. J Clin Oncol 2010; 28:2467-2474.
25. Varadi V, Brendle A, Brandt A, et al. Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis. Eur J Cancer 2009; 45:3008-3016.
26. Rafnar T, Sulem P, Stacey SN, et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet 2009; 41:221-227.
27. Petersen GM, Amundadottir L, Fuchs CS, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15. 33. Nat Genet 2010; 42:224-228.
28. Zhou QL, Jiang ZY, Mabardy AS, et al. A novel pleckstrin homology domaincontaining protein enhances insulin-stimulated Akt phosphorylation and GLUT4 translocation in adipocytes. J Biol Chem 2010; 285:27581-27589.
29. Chen H, Chen Y, Zhao Y, et al. Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15. 33) with glioma susceptibility in a Chinese population. Am J Epidemiol 2011; 173:915-922.